Valeant Pharmaceuticals International, Inc. (BVF.F)
| Previous close | 8.27 |
| Open | 7.48 |
| Bid | 0.00 x 31000 |
| Ask | 0.00 x 31000 |
| Day's range | 7.48 - 7.48 |
| 52-week range | 5.14 - 9.82 |
| Volume | |
| Avg. volume | 150 |
| Market cap | 2.745B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 10 Nov 2010 |
| 1y target est | N/A |
- Insider Monkey
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript May 1, 2024 Bausch + Lomb Corporation misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.09. Bausch + Lomb Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
- Insider Monkey
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript May 2, 2024 Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
- Zacks
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
Bausch's (BHC) first-quarter earnings and sales miss their respective estimates. Its shares fall in response to the results.
